Not provided
Not provided
Not provided
Not provided
Not provided
Unable to complete full enrollment due to Covid pandemic.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Procter and Gamble | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
This study evaluates the efficacy of multi-odorant enrichment on cognitive skills, olfactory function, and quality of life.
The purpose of this study is to explore sensory stimulation as a potential means of enhancing cognitive abilities. In mice, multi-odorant enrichment has been shown to increase neurogenesis in a critical memory pathway and thereby improve memory. In this clinical study, we will determine if a nightly sensory enrichment regimen using scents for 6 months can improve cognitive skills, as measured using a series of cognitive assessments and brain imaging in older adults. We also will determine if mood/mental state of mind or olfactory functioning improve following scent stimulation.
This study will enroll approximately 200 participants. Of the 200 participants in the study, 50 individuals, who are interested in participating, will have a functional Magnetic Resonance Imaging (fMRI) scan at the beginning and end of the study, which will be used to examine changes in the brain.
Participants will undergo cognitive assessments, computerized cognitive assessments, and olfactory function assessments. They will be randomly assigned to either an experimental or an active control group, and will be exposed to either a higher or lower concentration of essential oils nightly using a nebulizing fragrance diffuser, rotating through seven different scents, one per night. The exposures will continue for 6 months, after which the participants will return and undergo the same assessments conducted at the beginning of the study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental group | Experimental | Individuals in this group receive exposure to a higher concentration of essential oil fragrances nightly. |
|
| Active control group | Placebo Comparator | Individuals in this group receive exposure to a lower concentration of essential oil fragrances nightly. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| olfactory enrichment (essential oils) | Other | Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of behavioral pattern separation ability | Change in lure discrimination index on a computerized mnemonic discrimination task. | 1) at Baseline and 2) after 6 months of intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of cognition | Change in cognitive ability will be measured using scores from a neuropsychological battery. For each subsection, a change score will be calculated using the difference between baseline and 6-month scores, and the change score will be compared between groups. Higher values indicate a better outcome. | 1) at Baseline and 2) after 6 months of intervention |
Not provided
Inclusion Criteria:
Are age 60-85, male or female
Have normal cognition (determined at first assessment with cognitive testing)
Speak/read/understand English fluently
Have visual and auditory acuity adequate for neuropsychological and computerized testing
Are in good general health with no disease(s) expected to interfere with the study
Are willing and able to participate for the duration of the study and in all study procedures
Are able to smell scents
Are willing to refrain from using scented candles, scented oils, or air fresheners while participating in the study
Are willing to travel to the research site for testing
If interested in functional Magnetic Resonance Imaging (fMRI),
Are willing and able to participate in the fMRI scan.
Exclusion Criteria:
Have known fragrance sensitivities
Have asthma, allergies, or a fragrance sensitivity, which produces symptoms similar to those of an allergy, including runny nose, watery eyes, sneezing, or skin rash
Have a neurologic disease such as Parkinson's disease, multiple sclerosis, brain cyst, tumor or aneurysm
Have major health conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension, nutritional deficiency or thyroid disease
Have significant psychiatric disorders such as schizophrenia, bipolar disorder, anxiety disorder, or attention-deficit hyperactivity disorder
Have cognitive impairment when tested at baseline (defined as a score on any neuropsychological test of 1.5 standard deviations or more outside the age norm)
Have had alcohol or substance abuse or dependence within the past 2 years (DSM-IV criteria)
Smoke cigarettes, e-cigarettes, cigars, marijuana, or any other substance that could produce an interfering odor for the study.
If interested in functional Magnetic Resonance Imaging (fMRI),
MRI contraindications, (e.g. pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body).
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Leon, PhD | University of California, Irvine | Principal Investigator |
| Michael Yassa, PhD | University of California, Irvine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California Irvine | Irvine | California | 92697 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008569 | Memory Disorders |
| D000086582 | Anosmia |
| ID | Term |
|---|---|
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D009822 | Oils, Volatile |
| ID | Term |
|---|---|
| D009821 | Oils |
| D008055 | Lipids |
Not provided
Not provided
Participants will be randomly assigned to either an experimental group or an active control group.
Not provided
Not provided
Both the participants and the assessors will be blinded to the group assignments.
|
| Evaluation of depression | Change in depression status using the Beck Depression Inventory. | 1) at Baseline and 2) after 6 months of intervention |
| Evaluation of quality of life | Change in quality of life using the Farage Quality of Life questionnaire. | 1) at Baseline and 2) after 6 months of intervention |
| Evaluation of olfactory function | Change from baseline score on the Sniffin' Sticks instrument to assess olfactory system functioning. | 1) at Baseline and 2) after 6 months of intervention |
| Evaluation of change in brain structural connectivity | Change in perforant path integrity using functional Magnetic Resonance Imaging. | 1) at Baseline and 2) after 6 months of intervention |
| Evaluation of change in brain structures | Change in thickness of entorhinal cortex using functional Magnetic Resonance Imaging. | 1) at Baseline and 2) after 6 months of intervention |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D000857 | Olfaction Disorders |
| D012678 | Sensation Disorders |